Former DSM CEO named to Bühler board

Christoph Goppelsroeder was CEO of DSM from 2013 until his retirement in April

Christoph Goppelsroeder, former president and CEO of DSM Nutritional Products, was unanimously elected to Bühler Group’s board of directors on October 8.

Swiss national Goppelsroeder, 62, began his career at The Boston Consulting Group. From 1994 to 2003, he held management positions at Roche Vitamins in Switzerland, Belgium, and the U.S. He joined DSM through its acquisition of Roche’s Vitamins business in 2003 when he co-led the integration of Roche Vitamins and acted as DSM Managing Board member from 2005 to 2006. From 2007 to 2012, he oversaw Syngenta’s Global Seed Care Division. In 2013, Goppelsroeder was appointed president and CEO of DSM Nutritional Products, DSM’s largest business, and member of DSM’s Executive Committee. He led the division on a robust growth path, organically as well as through acquisitions. He retired on April 1, 2021.

Goppelsroeder studied civil engineering at ETH in Zurich and holds an MBA from Insead, Fontainebleau.